InvestorRoom | Kitov Pharmaceuticals http://kitovpharma.investorroom.com/ TyrNovo Ltd. to Participate in 2017 BIO International Convention http://kitovpharma.investorroom.com/news-releases?item=49 Company Selected by Israel Innovation Authority to Take Part in Israel Pavilion at World's Leading Biotech Conference Thu, 15 Jun 2017 10:58:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=49 Kitov Pharmaceuticals Files 6-K with Update on Israeli Securities Authority Investigation http://kitovpharma.investorroom.com/news-releases?item=47 Mon, 01 May 2017 10:23:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=47 U.S. Food and Drug Administration Grants Kitov a Waiver for New Drug Application Filing Fee http://kitovpharma.investorroom.com/news-releases?item=46 Mon, 03 Apr 2017 02:25:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=46 TyrNovo, a Kitov company, to Present Preclinical Data at the American Association for Cancer Research Annual Meeting http://kitovpharma.investorroom.com/news-releases?item=45 Mon, 27 Mar 2017 08:58:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=45 Kitov Announces License Agreement for KIT-302 in South Korea http://kitovpharma.investorroom.com/news-releases?item=44 Wed, 08 Mar 2017 09:03:00 -0500 http://kitovpharma.investorroom.com/news-releases?item=44